Stephanie Meier
Basel, BS 4031, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 12, 2025
SwissGenVar: A Platform for Clinical-Grade Interpretation of Genetic Variants to Foster Personalized Healthcare in Switzerland.
Journal: Journal of personalized medicine
Published: April 04, 2024
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 14, 2024
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Journal: JAMA neurology
Published: February 06, 2023
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: January 30, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 18, 2022
Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study).
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 02, 2021
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
Journal: Annals of neurology
Published: November 22, 2021
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 06, 2021
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Journal: The Lancet. Neurology
Published: May 19, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
Journal: Annals of neurology
Published: March 08, 2021
Last Updated: 09/26/2026